Filtern
Volltext vorhanden
- ja (7)
Gehört zur Bibliographie
- ja (7)
Dokumenttyp
Sprache
- Englisch (7)
Schlagworte
- RCC (2)
- biomarker (2)
- Biomarker (1)
- Biopsy (1)
- EAU guidelines (1)
- Hemospermia (1)
- Kidney cancer (1)
- Metastatic melanoma (1)
- Profiling (1)
- Prognosis (1)
- Renal cell carcinoma (1)
- Seminal vesicle tumor (1)
- T1 (1)
- Tumour markers (1)
- Ultrasound (1)
- aquaporin 3 protein (1)
- bacillus calmette guerin (1)
- controlled clinical-trials (1)
- follow up (1)
- forecasting (1)
- growth (1)
- high-risk prostate cancer (1)
- immunohistochemistry (1)
- in vitro (1)
- journals (1)
- kidney cancer (1)
- kidney neoplasms (1)
- kidneys (1)
- metastasis (1)
- miR (1)
- miR-126 (1)
- miR-205 (1)
- miR-21 (1)
- miRNA (1)
- microRNA (1)
- prognosis (1)
- progression (1)
- proliferation (1)
- prostatic neoplasms (1)
- radical cystectomy (1)
- randomized controlled trial (1)
- recurrence (1)
- regression analysis (1)
- renal cancer (1)
- renal cell carcinoma (1)
- risk stratification (1)
- stage pT1 (1)
- surgery (1)
- surgical and invasive medical procedures (1)
- surgical oncology (1)
- testicular neoplasms (1)
- transitional cell carcinoma (1)
- tumor (1)
- update (1)
- urinary bladder neoplasms (1)
- urothelial bladder carcinoma (1)
- venous infiltration (1)
- water channels (1)
Institut
Sonstige beteiligte Institutionen
(1) Background: Clear cell renal cell carcinoma extending into the inferior vena cava (ccRCC\(^{IVC}\)) represents a clinical high-risk setting. However, there is substantial heterogeneity within this patient subgroup regarding survival outcomes. Previously, members of our group developed a microRNA(miR)-based risk classifier — containing miR-21-5p, miR-126-3p and miR-221-3p expression — which significantly predicted the cancer-specific survival (CSS) of ccRCC\(^{IVC}\) patients. (2) Methods: Examining a single-center cohort of tumor tissue from n = 56 patients with ccRCC\(^{IVC}\), we measured the expression levels of miR-21, miR-126, and miR-221 using qRT-PCR. The prognostic impact of clinicopathological parameters and miR expression were investigated via single-variable and multivariable Cox regression. Referring to the previously established risk classifier, we performed Kaplan–Meier analyses for single miR expression levels and the combined risk classifier. Cut-off values and weights within the risk classifier were taken from the previous study. (3) Results: miR-21 and miR-126 expression were significantly associated with lymphonodal status at the time of surgery, the development of metastasis during follow-up, and cancer-related death. In Kaplan–Meier analyses, miR-21 and miR-126 significantly impacted CSS in our cohort. Moreover, applying the miR-based risk classifier significantly stratified ccRCC\(^{IVC}\) according to CSS. (4) Conclusions: In our retrospective analysis, we successfully validated the miR-based risk classifier within an independent ccRCC\(^{IVC}\) cohort.